BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients (2011)
Source: Oncogene. Unidades: FMRP, ICB, FCFRP
Assunto: IMUNOLOGIA
ABNT
CARVALHO, Daniel Diniz de et al. BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients. Oncogene, v. 30, n. 2, p. 223-233, 2011Tradução . . Disponível em: https://doi.org/10.1038/onc.2010.409. Acesso em: 27 ago. 2024.APA
Carvalho, D. D. de, Binato, R., Pereira, W. de O., Leroy, J. M. G., Colassanti, M. D., Proto-Siqueira, R., et al. (2011). BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients. Oncogene, 30( 2), 223-233. doi:10.1038/onc.2010.409NLM
Carvalho DD de, Binato R, Pereira W de O, Leroy JMG, Colassanti MD, Proto-Siqueira R, Silva AEBB da, Zago MA, Zanichelli MA, Abdelhay E, Castro FA de, Jacysyn JF, Amarante-Mendes JGP. BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients [Internet]. Oncogene. 2011 ; 30( 2): 223-233.[citado 2024 ago. 27 ] Available from: https://doi.org/10.1038/onc.2010.409Vancouver
Carvalho DD de, Binato R, Pereira W de O, Leroy JMG, Colassanti MD, Proto-Siqueira R, Silva AEBB da, Zago MA, Zanichelli MA, Abdelhay E, Castro FA de, Jacysyn JF, Amarante-Mendes JGP. BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients [Internet]. Oncogene. 2011 ; 30( 2): 223-233.[citado 2024 ago. 27 ] Available from: https://doi.org/10.1038/onc.2010.409